<--- Back to Details
First PageDocument Content
Cardiac electrophysiology / Pharmaceutical industry / Medicine / Implanted cardiac resynchronization device / Clinical endpoint / Artificial cardiac pacemaker / Adverse event / Clinical trial / Cardiology Trials Quick Review / Clinical research / Science / Research
Date: 2004-07-27 11:26:57
Cardiac electrophysiology
Pharmaceutical industry
Medicine
Implanted cardiac resynchronization device
Clinical endpoint
Artificial cardiac pacemaker
Adverse event
Clinical trial
Cardiology Trials Quick Review
Clinical research
Science
Research

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 287,50 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document